Linked Data Explorerhttp://worldcat.org/entity/work/id/1858055024
Re-inventing drug development
"The biopharmaceutical industry has entered an era of unprecedented change and challenge, characterized by increasing pricing pressures, rising rates of attrition in the product development lifecycle, and decreasing scientific innovation. The most successful products are losing patent protection, and pipelines have been unable to fill the gap. This book explores the evolving definition of innovation in therapeutic product development and begins to examine its effects on and implications to the life sciences R & D industry visavis collaboration, communication, and integration"--Provided by publisher.
Open All Close All
http://schema.org/about
- http://experiment.worldcat.org/entity/work/data/1858055024#Topic/drug_development
- http://experiment.worldcat.org/entity/work/data/1858055024#Topic/drug_industry_organization_&_administration
- http://experiment.worldcat.org/entity/work/data/1858055024#Topic/business_&_economics_industries_general
- http://experiment.worldcat.org/entity/work/data/1858055024#Topic/drug_discovery
- http://experiment.worldcat.org/entity/work/data/1858055024#Topic/pharmaceutical_industry
http://schema.org/alternateName
- "Reinventing drug development"@en
http://schema.org/description
- ""The biopharmaceutical industry has entered an era of unprecedented change and challenge, characterized by increasing pricing pressures, rising rates of attrition in the product development lifecycle, and decreasing scientific innovation. The most successful products are losing patent protection, and pipelines have been unable to fill the gap. This book explores the evolving definition of innovation in therapeutic product development and begins to examine its effects on and implications to the life sciences R & D industry visavis collaboration, communication, and integration"--Provided by publisher."@en
- ""The biopharmaceutical industry has entered an era of unprecedented change and challenge, characterized by increasing pricing pressures, rising rates of attrition in the product development lifecycle, and decreasing scientific innovation. The most successful products are losing patent protection, and pipelines have been unable to fill the gap. This book explores the evolving definition of innovation in therapeutic product development and begins to examine its effects on and implications to the life sciences R & D industry vis-a-vis collaboration, communication, and integration"--Provided by publisher."@en
- ""The biopharmaceutical industry has entered an era of unprecedented change and challenge, characterized by increasing pricing pressures, rising rates of attrition in the product development lifecycle, and decreasing scientific innovation. The most successful products are losing patent protection, and pipelines have been unable to fill the gap. This book explores the evolving definition of innovation in therapeutic product development and begins to examine its effects on and implications to the life sciences R & D industry vis-a-vis collaboration, communication, and integration"--Provided by publisher."
http://schema.org/genre
- "Electronic books"@en
- "Electronic books"
http://schema.org/name
- "Re-inventing drug development"@en
- "Re-inventing drug development"